Globe Life (NYSE:GL) CFO Thomas Peter Kalmbach Sells 11,790 Shares

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 11,790 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80. Following the completion of the transaction, the chief financial officer owned 40,972 shares in the company, valued at $6,228,563.44. This represents a 22.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.

Globe Life Price Performance

Shares of GL stock opened at $154.84 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $12.02 billion, a P/E ratio of 10.71 and a beta of 0.50. The company’s 50-day simple moving average is $145.44 and its two-hundred day simple moving average is $140.77. Globe Life Inc. has a one year low of $116.73 and a one year high of $156.69.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the business posted $3.07 earnings per share. Globe Life’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts anticipate that Globe Life Inc. will post 15.53 EPS for the current year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on GL. Wells Fargo & Company increased their price objective on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. Piper Sandler upgraded shares of Globe Life to a “strong-buy” rating in a research note on Thursday, April 2nd. Truist Financial increased their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, April 27th. Finally, Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $172.67.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after buying an additional 86,349 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Globe Life by 2.7% in the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after buying an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Globe Life by 10.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock worth $327,479,000 after buying an additional 217,331 shares during the last quarter. Morgan Stanley raised its holdings in shares of Globe Life by 7.2% in the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after buying an additional 125,567 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Globe Life by 32.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock worth $200,734,000 after buying an additional 355,399 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.